Navigation Links
Medela Announces Virtual Breast Milk Collection Campaign in Honor of Prematurity Awareness Month

McHenry, Ill., Nov. 1, 2012 /PRNewswire/ -- Human milk acts as a medicine for premature babies who are vulnerable to potentially fatal diseases such as necrotizing enterocolitis, an intestinal disease. To help demonstrate the importance of breastmilk and the NICU staff's role in facilitating access to it, and in honor of the  March of Dimes' National Prematurity Awareness Month Medela, Inc., will host its fourth annual Human Milk (breast milk) Collection Campaign. As part of the campaign, Medela will donate a total of $30,000 in breastfeeding support products to neonatal intensive care units across the country.

According to the American Academy of Pediatrics, UNICEF, and the U.S. Surgeon General, breast milk provides the optimal nutrition for babies.i,ii,iii  In the United States, the rate of premature births has been increasing, and this year more than 517,000 babies will be born premature.

"Breast milk for premature babies is critical, but breastfeeding in the NICU presents special challenges," says Carolin Archibald, president, Medela Inc.  "We're thrilled to be able to support National Prematurity Awareness Month by donating products to several NICUs.  The winning NICUs will be equipped with products to help mothers develop and maintain their breastmilk supply while their babies benefit from their milk."

Feeding human milk rather than formula in the NICU has been shown to reduce the length of hospital stay, days of oxygen therapy needed, and incidence of late-onset sepsis, necrotizing enterocolitis (NEC), ear infections, serious respiratory tract infections and gastroenteritis.

How the Campaign Works: 
Throughout the month of November, participants can visit to vote for their preferred Neonatal Intensive Care Unit (NICU). One NICU from each of six geographic regions will receive $5,000 worth of Medela products for their facility, including Symphony® Preemie+™ program cards, Symphony breastpumps, Waterless Milk Warmers™, Transport/Discharge Bags, BabyWeigh II™ scales. Voting is open to the general public and NICUs are encouraged to campaign for votes. Each person may vote only once and voting begins November 1 and continues through November 30.  For full details on the promotion, please visit

About Medela:   
Medela provides the most technologically advanced breastpumps and breastfeeding accessories to nursing mothers around the world. A long-time champion of breastfeeding, Medela is the only company to develop products based on research by the world's leading lactation experts. As a result, Medela's breastpumps are the number one choice of healthcare professionals and facilities worldwide.

Medela has developed an extensive line of products to meet the diverse needs of nursing mothers.  These products include hospital-grade, double and single electric and manual personal breastpumps; breastfeeding accessories such as breast care products and specialty feeding devices. Most recently, Medela introduced 2-Phase Expression®, the only research-based breastpump technology that mimics a baby's nursing rhythm, resulting in faster let-down and milk flow.

Founded in 1961 by Olle Larsson in Zug, Switzerland, Medela continues to grow under the ownership of the Larsson family. Medela serves customers through a worldwide network of distribution partners in more than 90 countries and its 15 subsidiaries in Australia, the Benelux countries, Canada, China, France, Germany, Italy, Japan, Russia, the United Kingdom, the United States, Spain, Sweden, Poland and Switzerland.

[i] American Academy of Pediatrics. Accessed August 7, 2012.

[ii] UNICEF. Accessed August 7, 2012.

[iii] U.S. Department of Health and Human Services. Accessed August 7, 2012.

Media Contact: 
Claudette Yasell 

Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Latest Findings in Breastfeeding Science Presented at Medelas 7th International Breastfeeding and Lactation Symposium
2. Janssen Announces Collaboration with Vertex on Phase 2 Study to Investigate an All-Oral Regimen of Simeprevir (TMC435) and VX-135 for Treatment of Hepatitis C
3. Anthera Announces the Phase 2b PEARL-SC Data Has Been Accepted as a Late Breaking Poster Presentation at the ACR/ARHP 2012 Annual Scientific Meeting
4. Watson Announces Global Generics Management Team
5. Watson Announces New Name -- Actavis -- for Global Operations
6. BioMed Realty Announces 93,000 Square Foot Lease Expansion And Extension With Ironwood Pharmaceuticals At 301 Binney Street
7. Abaxis Announces Exclusive Distribution Agreement with Abbott
8. Thesan Pharmaceuticals Announces Series A Funding Co-Led By Novo Ventures And Novartis Venture Funds
9. Lilly Names Melissa Barnes Chief Ethics and Compliance Officer and Senior Vice President; Announces Retirement of Anne Nobles
10. Neuraltus Pharmaceuticals Announces Phase 2 Clinical Results for NP001 in Patients with Amyotrophic Lateral Sclerosis (ALS)
11. Jazz Pharmaceuticals Announces Date to Release Third Quarter 2012 Results
Post Your Comments:
(Date:11/25/2015)... THOUSAND OAKS, Calif. , Nov. 25, 2015 /PRNewswire/ ... of a Biologics License Application (BLA) with ... Administration (FDA) for ABP 501, a biosimilar candidate to ... the first adalimumab biosimilar application submitted to the FDA ... biosimilar pathway. Sean E. Harper , M.D., ...
(Date:11/25/2015)... On Tuesday, November 24, 2015, the ... Wright Medical Technology, Inc. for product liability and ... implant device, awarded $11 million in favor of ... and three days of deliberations, the jury found ... designed and unreasonably dangerous, and that Wright Medical ...
(Date:11/25/2015)... -- Allergan plc (NYSE: AGN ) today announced that ... York State Attorney General,s Office to end the ... statutes with the Attorney General over the decision of Forest ... selling the now generic version of memantine immediate release tablets.  ... released its counterclaims against New York , ...
Breaking Medicine Technology:
(Date:11/27/2015)... ... November 27, 2015 , ... According to an article ... the way that they are handling security in light of the recent terrorist attacks ... in an attempt to stop an attack from reaching U.S. soil. Especially around special ...
(Date:11/27/2015)... ... November 27, 2015 , ... A team of Swiss ... to treat it. Surviving Mesothelioma has just posted the findings on the website. ... Zurich analyzed the cases of 136 mesothelioma patients who were treated with chemotherapy followed ...
(Date:11/27/2015)... ... November 27, 2015 , ... "When ... said an inventor from Hillside, N.J. "Many people catch diseases simply from sitting ... individuals will always be protected from germs." , He developed the patent-pending QUDRATECS ...
(Date:11/27/2015)... ... ... The print component of “Supporting Our Caregivers” is distributed ... Minneapolis, South Florida, with a circulation of approximately 250,000 copies and an estimated ... media strategy and across a network of top news sites and partner media ...
(Date:11/27/2015)... ... ... MPWH, the No.1 Herpes-only dating community in the world, revealed that over 50% of its ... 3.7 billion people under the age of 50 – or 67% of the population - ... estimates of HSV-1 infection . , "The data shocks us highly!" said Michelle Li, ...
Breaking Medicine News(10 mins):